Evaluation of the Support Program to Enhance Self-management Capacity Among Stroke Survivors

March 10, 2026 updated by: Pham Ngoc Thach University of Medicine

The goal of this interventional study is to develop and evaluate a post-stroke patient support program aimed at enhancing patients' ability to self-management after discharge to home. The main question it aim to answer are:

After participating in the support program, do patients show improvements in stroke-related knowledge, independence in activities of daily living, and self-efficacy in managing their health?

Researchers will compare intervention to control group. The control group receive usual care. The intervention group receive usual care and support self management program to see enhance self-efficacy and recovery.

Participants will:

  • Answer a self-report questionnaire
  • Attend to support self management program during 5 sessions in 5 weeks

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

140

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 years or older;
  • Clinically diagnosed with ischemic stroke or intracerebral hemorrhage (first-ever or recurrent episode);
  • Assessed by the treating physician as being clinically stable following the acute phase;
  • Mini-Mental State Examination (MMSE) score > 18;
  • Scheduled for follow-up after discharge at the Neurology Outpatient Clinic or the Neurology Clinic, Department of Outpatient Services, University Medical Center Ho Chi Minh City;
  • Able to speak and read Vietnamese;
  • Willing to participate in educational sessions within the health self-management program;
  • Able to use a telephone;
  • Having a family member or caregiver accompanying the patient who is able to recognize changes in the patient's physical and mental condition;
  • Providing informed consent to participate in the study.

Exclusion Criteria:

  • Diagnosed with stroke secondary to cerebrovascular pathology related to malignancy;
  • Diagnosed with psychiatric disorders such as depression, schizophrenia, bipolar disorder, or personality disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The intervention group receive usual care and support self management program
Usual care
Five sessions per five weeks of support self management program included stroke education and action planning; deliver rehabilitation, fall prevention, and problem-solving guidance; review progress and refine weekly action plans; reinforce adherence through follow-up; and summarize outcomes while establishing a continued self-management plan.
Other: Control
The control group receive usual care.
Usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self - Efficacy
Time Frame: Five weeks after stroke
Using Stroke self-efficacy questionnaire (SSEQ). Total score ranging from 0 to 130, which is positive corelation to self-efficacy level.
Five weeks after stroke

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke self - management behaviors
Time Frame: Five weeks after stroke
The level of independence in activities of daily living (Barthel Index)
Five weeks after stroke

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke Knowledge
Time Frame: Five weeks after stroke
Stroke Knowledge test
Five weeks after stroke

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

March 6, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Usual care

Subscribe